PROK (ProKidney) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PROK ProKidney Corp PROK
25 GF Score
Price $1.62
! 2 Warning Signs
View Full Analysis

What is ProKidney FFO?

FFO (Funds from operations) only applies to REITs.

PROK
25GF Score
ProKidney Corp PROK
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ProKidney Business Description

Other Exchanges PROK:Mexico
Address 2000 Frontis Plaza Boulevard, Suite 250, Winston-Salem, NC, USA, 27103
ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its product candidate, REACT (Renal Autologous Cell Therapy), is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
25GF Score

Get the complete analysis for PROK

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.62
Price